A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysis

Filip Mussen; Sam Salek; Stuart Walker

doi:10.1002/pds.1435

A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysis

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.1435 ◽

2007 ◽

Vol 16 (S1) ◽

pp. S2-S15 ◽

Cited By ~ 72

Author(s):

Filip Mussen ◽

Sam Salek ◽

Stuart Walker

Keyword(s):

Risk Assessment ◽

Decision Analysis ◽

Quantitative Approach ◽

New Model ◽

Multi Criteria Decision Analysis ◽

Benefit Risk Assessment

Download Full-text

A quantitative approach to benefit-risk assessment of medicines—part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new model

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.1436 ◽

2007 ◽

Vol 16 (S1) ◽

pp. S42-S46 ◽

Cited By ~ 12

Author(s):

Filip Mussen ◽

Sam Salek ◽

Stuart Walker

Keyword(s):

Risk Assessment ◽

Decision Analysis ◽

Quantitative Approach ◽

Practical Application ◽

New Model ◽

Multi Criteria Decision Analysis ◽

Benefit Risk Assessment

Download Full-text

Retracted: A quantitative approach to benefit-risk assessment of medicines–part 2; the practical application of a new model Filip Mussen, Sam Salek, Stuart Walker

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.1505 ◽

2007 ◽

Vol 16 (10) ◽

pp. 1180-1180 ◽

Cited By ~ 2

Author(s):

Ronald D. Mann

Keyword(s):

Risk Assessment ◽

Quantitative Approach ◽

Practical Application ◽

New Model ◽

Benefit Risk Assessment

Download Full-text

Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis

Clinical Therapeutics ◽

10.1016/j.clinthera.2018.12.015 ◽

2019 ◽

Vol 41 (2) ◽

pp. 249-260.e18 ◽

Cited By ~ 8

Author(s):

Patrick Vermersch ◽

Vittorio Martinelli ◽

Claudia Pfleger ◽

Peter Rieckmann ◽

Lucia Alonso-Magdalena ◽

...

Keyword(s):

Multiple Sclerosis ◽

Risk Assessment ◽

Decision Analysis ◽

Multi Criteria Decision Analysis ◽

Benefit Risk Assessment ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Development and Application of a Benefit–Risk Assessment Model Based on Multi-Criteria Decision Analysis

Benefit-Risk Appraisal of Medicines ◽

10.1002/9780470748114.ch5 ◽

2009 ◽

pp. 111-149 ◽

Cited By ~ 1

Keyword(s):

Risk Assessment ◽

Decision Analysis ◽

Assessment Model ◽

Risk Assessment Model ◽

Multi Criteria Decision Analysis ◽

Model Based ◽

Benefit Risk Assessment

Download Full-text

Erratum: A quantitative approach to benefit-risk assessment of medicines — part 2: the practical application of a new model

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.1460 ◽

2007 ◽

Vol 16 (8) ◽

pp. 946-946 ◽

Cited By ~ 3

Author(s):

Filip Mussen ◽

Sam Salek ◽

Stuart Walker

Keyword(s):

Risk Assessment ◽

Quantitative Approach ◽

Practical Application ◽

New Model ◽

Benefit Risk Assessment

Download Full-text

A BENEFIT/RISK ASSESSMENT OF POSTOPERATIVE, PARENTERAL, NON-OPIOID ANALGESICS USING MULTI-CRITERIA DECISION ANALYSIS (MCDA)

10.26226/morressier.5b519f6cb1b87b000ecf1566 ◽

2018 ◽

Author(s):

Margaret N Essex ◽

Dr Robert Pawinski

Keyword(s):

Risk Assessment ◽

Decision Analysis ◽

Opioid Analgesics ◽

Multi Criteria Decision Analysis ◽

Benefit Risk Assessment

Download Full-text

Retracted:A quantitative approach to benefit-risk assessment of medicines — part 2: the practical application of a new model

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.1434 ◽

2007 ◽

Vol 16 (S1) ◽

pp. S16-S41 ◽

Cited By ~ 12

Author(s):

Filip Mussen ◽

Sam Salek ◽

Stuart Walker

Keyword(s):

Risk Assessment ◽

Quantitative Approach ◽

Practical Application ◽

New Model ◽

Benefit Risk Assessment

Download Full-text

A Note on the Validity and Reliability of Multi-Criteria Decision Analysis for the Benefit–Risk Assessment of Medicines

Drug Safety ◽

10.1007/s40264-015-0344-2 ◽

2015 ◽

Vol 38 (11) ◽

pp. 1049-1057 ◽

Cited By ~ 2

Author(s):

Alberto Garcia-Hernandez

Keyword(s):

Risk Assessment ◽

Decision Analysis ◽

Validity And Reliability ◽

Multi Criteria Decision Analysis ◽

Benefit Risk Assessment

Download Full-text

Benefit-Risk Assessment of Statins (Lipid Lowering Agents): A Multi-Criteria Decision Analysis

Journal of Multi-Criteria Decision Analysis ◽

10.1002/mcda.1554 ◽

2015 ◽

Vol 23 (1-2) ◽

pp. 28-39 ◽

Cited By ~ 1

Author(s):

Tanatape Wanishayakorn ◽

Surachat Ngorsuraches

Keyword(s):

Risk Assessment ◽

Decision Analysis ◽

Lipid Lowering ◽

Multi Criteria Decision Analysis ◽

Benefit Risk Assessment ◽

Lipid Lowering Agents

Download Full-text

Coupling Multi-Criteria Decision Analysis, Life-Cycle Assessment, and Risk Assessment for Emerging Threats

Environmental Science & Technology ◽

10.1021/es100959q ◽

2011 ◽

Vol 45 (12) ◽

pp. 5068-5074 ◽

Cited By ~ 96

Author(s):

Igor Linkov ◽

Thomas P. Seager

Keyword(s):

Risk Assessment ◽

Life Cycle Assessment ◽

Life Cycle ◽

Decision Analysis ◽

Multi Criteria Decision Analysis

Download Full-text